A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma

A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma

PurposePatients with International Metastatic RCC Database Consortium (IMDC) poor risk metastatic renal cell carcinoma (mRCC) rarely respond to first-line tyrosine kinase inhibitors (TKIs) including sunitinib, and carries a very poor prognosis. In recent years, combination therapy involving immune c...

全面介绍

书目详细资料
Main Authors: Hyunji Jo, Joohyun Hong, Hongsik Kim, Hye Ryeon Kim, Ghee Young Kwon, Kyung A. Kang, Sung Yoon Park, Chan Kyo Kim, Byung Kwan Park, Jae Hoon Chung, Wan Song, Minyong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Se Hoon Park
格式: 文件
语言:English
出版: Frontiers Media S.A. 2022-04-01
丛编:Frontiers in Oncology
主题:
immunotherapy
immune checkpoint inhibitors
renal cell carcinoma
IMDC poor-risk
overall survival
sunitinib
在线阅读:https://www.frontiersin.org/articles/10.3389/fonc.2022.874385/full

因特网

https://www.frontiersin.org/articles/10.3389/fonc.2022.874385/full

相似书籍